CXCL12 and hepatocellular carcinoma: In vitro investigations conducted by Shuhai Chen and colleagues revealed that CAF enhances macrophage M2 polarization and CAF-secreted CXCL12 causes TAMs to release plasminogen activator inhibitor-1 (PAI-1), hence promoting HCC progression (Chen et al., 2021).